Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for the Vabra Aspirator, effective May 15, 2026. Here's what billing teams need to know before that date.
CMS updated its Vabra Aspirator coverage policy — a device used for endometrial sampling in gynecologic settings. The policy does not list a specific policy code in the CMS system, but the change carries real implications for Vabra Aspirator billing and reimbursement for OB/GYN and women's health practices billing to Medicare. This policy does not provide specific CPT or HCPCS codes in the source data, so confirm your applicable codes directly against your charge capture before May 15, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Vabra Aspirator |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium |
| Specialties Affected | OB/GYN, Women's Health, Gynecologic Oncology |
| Key Action | Review Vabra Aspirator claims and documentation against updated medical necessity criteria before May 15, 2026 |
CMS Vabra Aspirator Coverage Criteria and Medical Necessity Requirements 2026
The Vabra Aspirator is a suction-based device used to collect endometrial tissue samples. Clinicians use it primarily to diagnose conditions like endometrial hyperplasia or endometrial carcinoma — without requiring a formal dilation and curettage procedure in most cases.
CMS coverage policy for this device has historically tied reimbursement to whether the procedure meets medical necessity criteria for endometrial sampling. That means the clinical indication documented in the patient's record must support the use of the aspirator specifically — not just any gynecologic sampling technique.
Because this policy was modified on May 15, 2026, and the source document does not include a detailed summary of what specifically changed, your first step is to pull the full updated policy from the CMS source directly. You can access it at the PayerPolicy link for this change. Do not assume the prior criteria still apply unchanged.
What Medical Necessity Looks Like for Vabra Aspirator Claims
Medical necessity for endometrial sampling procedures typically requires documented clinical indications. These often include abnormal uterine bleeding, postmenopausal bleeding, or clinical suspicion of endometrial pathology. CMS expects that documentation — not just a diagnosis code — clearly supports why this device was used over alternatives.
If your practice bills for Vabra Aspirator procedures and relies on templated notes, this is a risk area. A templated note that doesn't connect the clinical picture to the specific tool used is a claim denial waiting to happen. Make sure your providers document the rationale explicitly.
Prior Authorization Under the Updated CMS Policy
The policy source data does not confirm whether prior authorization is now required under the modified coverage policy. That silence is not reassurance — it means you need to verify. Contact your Medicare Administrative Contractor directly to confirm whether prior auth applies to Vabra Aspirator procedures in your region as of May 15, 2026.
MAC-level local coverage determinations sometimes layer additional requirements on top of national CMS policy. Your MAC may have an LCD that governs endometrial sampling more specifically than the national policy. Check both.
CMS Vabra Aspirator Exclusions and Non-Covered Indications
The source policy data does not specify explicit exclusions for the Vabra Aspirator under this modified coverage policy. However, CMS generally does not cover procedures that duplicate other same-session services or that lack documented clinical justification.
One area to watch: if a provider performs endometrial sampling and a separate diagnostic procedure in the same session, unbundling rules apply. CMS and its MACs scrutinize same-day gynecologic procedure billing closely. If your team bills both a Vabra Aspirator procedure and a hysteroscopy or biopsy on the same date of service, review the applicable NCCI edits before submitting.
The absence of a detailed exclusion list in the current policy data does not mean there are no exclusions. It means the full policy text — available through CMS directly or via the PayerPolicy source link — needs to be your reference document.
Coverage Indications at a Glance
Because the policy source does not provide a detailed summary of indication-level criteria, the table below reflects generally understood CMS coverage standards for Vabra Aspirator procedures. Verify each against the updated May 15, 2026 policy text before submitting claims.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Abnormal uterine bleeding with clinical suspicion of endometrial pathology | Generally Covered | Confirm with MAC | Medical necessity documentation required |
| Postmenopausal bleeding evaluation | Generally Covered | Confirm with MAC | Strong clinical documentation expected |
| Routine screening without clinical indication | Not Covered | N/A | CMS does not cover endometrial sampling as a screening tool without symptoms |
| Repeat sampling without documented clinical change | Likely Not Covered | Confirm with MAC | Prior results and clinical rationale must support repeat procedure |
CMS Vabra Aspirator Billing Guidelines and Action Items 2026
Here is what your billing team should do right now, before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Pull the full updated policy text from CMS. The source document for this change is at the PayerPolicy link above. Read it in full. Do not rely on summaries — including this one — as your sole reference when billing guidelines have changed. |
| 2 | Contact your Medicare Administrative Contractor. Ask specifically whether this policy modification changes prior authorization requirements or documentation standards for Vabra Aspirator procedures in your jurisdiction. MACs implement national policy with local variations, and those variations matter for claim approval. |
| 3 | Audit your current documentation templates. If your providers use templated notes for endometrial sampling, review them now. The note must connect the clinical indication to the use of the Vabra Aspirator specifically. Generic documentation will not meet medical necessity standards under CMS scrutiny. |
| 4 | Check for applicable NCCI edits. If your practice bills endometrial sampling alongside other gynecologic procedures in the same session, verify that your code combinations don't trigger bundling edits. A claim denial from an NCCI conflict is avoidable if you check before submission. |
| 5 | Flag any pending claims that straddle the effective date. Claims for services provided on or after May 15, 2026 need to meet the updated coverage policy criteria. If you have claims in queue that weren't reviewed under the new standards, pull them before they go out. |
| 6 | Loop in your compliance officer if you have volume. If your practice or system submits a significant number of Vabra Aspirator claims to Medicare, this policy modification warrants a compliance review — not just a billing team conversation. Your compliance officer should know about this change and sign off on your updated billing approach. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Vabra Aspirator Procedures Under This CMS Policy
The policy source data does not list specific CPT, HCPCS, or ICD-10 codes. Do not use codes from this post as your billing reference without verifying against the full CMS policy document and your MAC's LCD.
Codes to Research and Confirm
The procedures most commonly associated with Vabra Aspirator use in Medicare billing involve endometrial sampling codes. Your coding team should confirm the correct procedure codes with the full updated policy and your MAC before the May 15, 2026 effective date. Coding the wrong procedure or using an outdated code pairing is one of the most common sources of claim denial in gynecologic procedure billing.
If your compliance officer or coding consultant has not reviewed the applicable codes against the updated policy, that review needs to happen before May 15, 2026 — not after your first denial.
A Note on Code Assignment
Because no codes appear in the policy source data, PayerPolicy has not listed codes in this post. This is intentional. Inventing or assuming codes based on clinical context is how billing errors happen. The right call here is to source the codes from the actual CMS policy document and confirm with your MAC or a qualified coding consultant.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.